# Journey Medical (DERM) — Earnings

DERM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/derm/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.01 |
| EPS estimate | −$0.02 |
| EPS surprise | +55.56% |
| Revenue surprise | +0.82% |
| Revenue | $18.5M |
| Revenue estimate | $18.4M |
| Reported | Aug 12, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1867066/000110465926094948/derm-20260630x10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/fb834bb8-5b10-4341-c920-ec08cc5e762c.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 12, 2026 | −$0.02 | −$0.01 | 55.56% | $18.4M | $18.5M |
| Q1 2026 | May 13, 2026 | −$0.09 | −$0.08 | 8.57% | $15.5M | $16.0M |
| Q4 2025 | Mar 25, 2026 | −$0.04 | −$0.04 | 0.00% | $19.3M | $16.1M |
| Q3 2025 | Nov 12, 2025 | −$0.05 | −$0.09 | -89.47% | $18.9M | $17.6M |
| Q2 2025 | Aug 12, 2025 | −$0.11 | −$0.16 | -52.38% | $14.8M | $15.0M |
| Q1 2025 | May 14, 2025 | −$0.24 | −$0.18 | 24.21% | $12.1M | $13.1M |
| Q4 2024 | Mar 26, 2025 | −$0.20 | $0.10 | 150.63% | $14.0M | $13.6M |
| Q3 2024 | Nov 12, 2024 | −$0.17 | −$0.12 | 29.41% | $14.4M | $14.6M |
| Q2 2024 | Aug 12, 2024 | −$0.14 | −$0.17 | -18.63% | $13.9M | $14.9M |
| Q1 2024 | May 13, 2024 | −$0.24 | −$0.53 | -125.53% | $14.1M | $13.0M |
| Q4 2023 | Mar 21, 2024 | −$0.09 | −$0.59 | -594.12% | $14.9M | $15.3M |
| Q3 2023 | Nov 7, 2023 | −$0.16 | $0.99 | 738.71% | $16.9M | $34.5M |
| Q2 2023 | Aug 8, 2023 | −$0.34 | −$0.04 | 88.06% | $14.8M | $17.2M |
| Q1 2023 | May 22, 2023 | −$0.45 | −$0.57 | -27.60% | $16.2M | $12.2M |
| Q4 2022 | Mar 29, 2023 | −$0.47 | −$0.60 | -28.56% | $16.6M | $15.9M |
| Q3 2022 | Nov 10, 2022 | −$0.40 | −$0.23 | 42.02% | $17.7M | $16.1M |
| Q2 2022 | Aug 9, 2022 | −$0.26 | −$0.15 | 41.57% | $21.3M | $18.3M |
| Q1 2022 | May 10, 2022 | −$0.31 | −$0.08 | 74.19% | $22.2M | $23.3M |
| Q4 2021 | Mar 24, 2022 | −$0.41 | −$1.64 | -296.81% | $20.4M | $17.5M |
| Q3 2021 | Dec 10, 2021 | −$0.87 | −$1.16 | -33.33% | $19.5M | $19.6M |

## Frequently Asked Questions

### When did Journey Medical (DERM) last report earnings?

Journey Medical last reported on Aug 12, 2026, covering fiscal Q2 2026.

### Did DERM beat earnings estimates?

Yes. Journey Medical reported EPS of −$0.01 for Q2 2026 against a −$0.02 estimate — a 55.56% beat.

### How much revenue did DERM report last quarter?

Journey Medical reported $18.5M in revenue for Q2 2026, against a consensus estimate of $18.4M.

## Similar Stocks

- [FBIO](https://www.lighthorse.io/tickers/fbio) — Fortress Biotech, Inc. - Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).